Cargando…
“Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria
BACKGROUND: Nigeria has the second highest number of new HIV infections annually. Therefore, it is important to explore new strategies for preventing new infections. The introduction of pre-exposure prophylaxis (PrEP) for use by persons at high risk of HIV infection has new potential in preventing n...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404045/ https://www.ncbi.nlm.nih.gov/pubmed/25881087 http://dx.doi.org/10.1186/s12889-015-1690-9 |
_version_ | 1782367432750399488 |
---|---|
author | Idoko, John Folayan, Morenike Oluwatoyin Dadem, Nancin Yusufu Kolawole, Grace Oluwatosin Anenih, James Alhassan, Emmanuel |
author_facet | Idoko, John Folayan, Morenike Oluwatoyin Dadem, Nancin Yusufu Kolawole, Grace Oluwatosin Anenih, James Alhassan, Emmanuel |
author_sort | Idoko, John |
collection | PubMed |
description | BACKGROUND: Nigeria has the second highest number of new HIV infections annually. Therefore, it is important to explore new strategies for preventing new infections. The introduction of pre-exposure prophylaxis (PrEP) for use by persons at high risk of HIV infection has new potential in preventing new HIV infections. The aim of this study is to explore the public opinion, community interest, and perceptions about the use and access to PrEP in Nigeria. METHODS: This formative study used a mixed method approach to collect data on public opinions and perceptions on appropriate target groups for PrEP access, community interest, perceptions about the use of PrEP as an HIV-prevention tool, how best to communicate with participants about PrEP, concerns about PrEP use by serodiscordant couples, and suggestions for the design and implementation of a PrEP demonstration project. Telephone and in-depth interviews were conducted, and focus group discussions and consultative meetings were held with critical stakeholders engaged in HIV-prevention, treatment, care, and support programmes in Nigeria. An online survey was also conducted. RESULTS: HIV serodiscordant couples were identified as the appropriate target group for PrEP use. Most respondents felt that PrEP use by key affected populations would help reduce the HIV incidence. Stigma was identified as a major concern and a potential barrier for the acceptance and use of PrEP by HIV serodiscordant couples. Electronic and print media were identified as important means for massive public education to prevent stigma and create awareness about PrEP. In a male dominated society such as Nigeria, HIV-negative male partners in serodiscordant relationships may resist enrolment in PrEP programmes. This may be complicated by the fact that the identified index partner in most serodiscordant relationships in Nigeria is an HIV-positive woman, who is often diagnosed during pregnancy. CONCLUSIONS: PrEP uptake and use by HIV serodiscordant couples in Nigeria may face notable but surmountable challenges. Much depends on the appropriateness of actions taken by multiple players. Motivation of HIV-negative male partners to use PrEP and establishment of effective public education programmes in addressing stigma are essential. |
format | Online Article Text |
id | pubmed-4404045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44040452015-04-21 “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria Idoko, John Folayan, Morenike Oluwatoyin Dadem, Nancin Yusufu Kolawole, Grace Oluwatosin Anenih, James Alhassan, Emmanuel BMC Public Health Research Article BACKGROUND: Nigeria has the second highest number of new HIV infections annually. Therefore, it is important to explore new strategies for preventing new infections. The introduction of pre-exposure prophylaxis (PrEP) for use by persons at high risk of HIV infection has new potential in preventing new HIV infections. The aim of this study is to explore the public opinion, community interest, and perceptions about the use and access to PrEP in Nigeria. METHODS: This formative study used a mixed method approach to collect data on public opinions and perceptions on appropriate target groups for PrEP access, community interest, perceptions about the use of PrEP as an HIV-prevention tool, how best to communicate with participants about PrEP, concerns about PrEP use by serodiscordant couples, and suggestions for the design and implementation of a PrEP demonstration project. Telephone and in-depth interviews were conducted, and focus group discussions and consultative meetings were held with critical stakeholders engaged in HIV-prevention, treatment, care, and support programmes in Nigeria. An online survey was also conducted. RESULTS: HIV serodiscordant couples were identified as the appropriate target group for PrEP use. Most respondents felt that PrEP use by key affected populations would help reduce the HIV incidence. Stigma was identified as a major concern and a potential barrier for the acceptance and use of PrEP by HIV serodiscordant couples. Electronic and print media were identified as important means for massive public education to prevent stigma and create awareness about PrEP. In a male dominated society such as Nigeria, HIV-negative male partners in serodiscordant relationships may resist enrolment in PrEP programmes. This may be complicated by the fact that the identified index partner in most serodiscordant relationships in Nigeria is an HIV-positive woman, who is often diagnosed during pregnancy. CONCLUSIONS: PrEP uptake and use by HIV serodiscordant couples in Nigeria may face notable but surmountable challenges. Much depends on the appropriateness of actions taken by multiple players. Motivation of HIV-negative male partners to use PrEP and establishment of effective public education programmes in addressing stigma are essential. BioMed Central 2015-04-10 /pmc/articles/PMC4404045/ /pubmed/25881087 http://dx.doi.org/10.1186/s12889-015-1690-9 Text en © Idoko et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Idoko, John Folayan, Morenike Oluwatoyin Dadem, Nancin Yusufu Kolawole, Grace Oluwatosin Anenih, James Alhassan, Emmanuel “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria |
title | “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria |
title_full | “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria |
title_fullStr | “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria |
title_full_unstemmed | “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria |
title_short | “Why should I take drugs for your infection?”: outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria |
title_sort | “why should i take drugs for your infection?”: outcomes of formative research on the use of hiv pre-exposure prophylaxis in nigeria |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404045/ https://www.ncbi.nlm.nih.gov/pubmed/25881087 http://dx.doi.org/10.1186/s12889-015-1690-9 |
work_keys_str_mv | AT idokojohn whyshoulditakedrugsforyourinfectionoutcomesofformativeresearchontheuseofhivpreexposureprophylaxisinnigeria AT folayanmorenikeoluwatoyin whyshoulditakedrugsforyourinfectionoutcomesofformativeresearchontheuseofhivpreexposureprophylaxisinnigeria AT dademnancinyusufu whyshoulditakedrugsforyourinfectionoutcomesofformativeresearchontheuseofhivpreexposureprophylaxisinnigeria AT kolawolegraceoluwatosin whyshoulditakedrugsforyourinfectionoutcomesofformativeresearchontheuseofhivpreexposureprophylaxisinnigeria AT anenihjames whyshoulditakedrugsforyourinfectionoutcomesofformativeresearchontheuseofhivpreexposureprophylaxisinnigeria AT alhassanemmanuel whyshoulditakedrugsforyourinfectionoutcomesofformativeresearchontheuseofhivpreexposureprophylaxisinnigeria |